Zydus Cadila gets FDA nod for generic Reyataz

Press enter to search
Close search
Open Menu

Zydus Cadila gets FDA nod for generic Reyataz

By Sandra Levy - 06/05/2020

Patients with HIV will soon have a new generic antiretroviral drug treatment.

The Food and Drug Administration has cleared Zydus Cadila's atazanavir capsules in dosage strengths of 150 mg, 200 mg and 300 mg.

The product is the generic of Bristol Myers Squibb’s Reyataz capsules.

It is used in combination with other antiretroviral drugs to treat HIV-1 infection.

The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.

Related Topics